دورية أكاديمية

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

التفاصيل البيبلوغرافية
العنوان: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
المؤلفون: Ally, A, Balasundaram, M, Carlsen, R, Chuah, E, Clarke, A, Dhalla, N, Holt, RA, Jones, SJM, Lee, D, Ma, Y, Marra, MA, Mayo, M, Moore, RA, Mungall, AJ, Schein, JE, Sipahimalani, P, Tam, A, Thiessen, N, Cheung, D, Wong, T, Brooks, D, Robertson, AG, Bowlby, R, Mungall, K, Sadeghi, S, Xi, L, Covington, K, Shinbrot, E, Wheeler, DA, Gibbs, RA, Donehower, LA, Wang, L, Bowen, J, Gastier-Foster, JM, Gerken, M, Helsel, C, Leraas, KM, Lichtenberg, TM, Ramirez, NC, Wise, L, Zmuda, E, Gabriel, SB, Meyerson, M, Cibulskis, C, Murray, BA, Shih, J, Beroukhim, R, Cherniack, AD, Schumacher, SE, Saksena, G, Pedamallu, CS, Chin, L, Getz, G, Noble, M, Zhang, H, Heiman, D, Cho, J, Gehlenborg, N, Voet, D, Lin, P, Frazer, S, Defreitas, T, Meier, S, Lawrence, M, Kim, J, Creighton, CJ, Muzny, D, Doddapaneni, H, Hu, J, Wang, M, Morton, D, Korchina, V, Han, Y, Dinh, H, Lewis, L, Bellair, M, Liu, X, Santibanez, J, Glenn, R, Lee, S, Hale, W, Parker, JS, Wilkerson, MD, Hayes, DN, Reynolds, SM, Shmulevich, I, Zhang, W, Liu, Y, Iype, L, Makhlouf, H, Torbenson, MS, Kakar, S, Yeh, MM, Kleiner, DE, Jain, D, Dhanasekaran, R, El-Serag, HB, Yim, SY, Weinstein, JN, Mishra, L, Zhang, J, Akbani, R, Ling, S, Ju, Z, Su, X, Hegde, AM, Mills, GB, Lu, Y, Chen, J, Lee, J-S, Sohn, BH, Shim, JJ, Tong, P, Aburatani, H, Yamamoto, S, Tatsuno, K, Li, W, Xia, Z, Stransky, N, Seiser, E, Innocenti, F, Gao, J, Kundra, R, Heins, Z, Ochoa, A, Sander, C, Ladanyi, M, Shen, R, Arora, A, Sanchez-Vega, F, Schultz, N, Kasaian, K, Radenbaugh, A, Bissig, K-D, Moore, DD, Totoki, Y, Nakamura, H, Shibata, T, Yau, C, Graim, K, Stuart, J, Haussler, D, Slagle, BL, Ojesina, AI, Katsonis, P, Koire, A, Lichtarge, O, Hsu, T-K, Ferguson, ML, Demchok, JA, Felau, I, Sheth, M, Tarnuzzer, R, Wang, Z, Yang, L, Zenklusen, JC, Hutter, CM, Sofia, HJ, Verhaak, RGW, Zheng, S, Lang, F, Chudamani, S, Liu, J, Lolla, L, Wu, Y, Naresh, R, Pihl, T, Sun, C, Wan, Y, Benz, C, Perou, AH, Thorne, LB, Boice, L, Huang, M, Rathmell, WK, Noushmehr, H, Saggioro, FP, Tirapelli, DPDC, Carlotti, CGJ, Mente, ED, Silva, ODC, Trevisan, FA, Kang, KJ, Ahn, KS, Giama, NH, Moser, CD, Giordano, TJ, Vinco, M, Welling, TH, Crain, D, Curley, E, Gardner, J, Mallery, D, Morris, S, Paulauskis, J, Penny, R, Shelton, C, Shelton, T, Kelley, RK, Park, J-W, Chandan, VS, Roberts, LR, Bathe, OF, Hagedorn, CH, Auman, JT, O'Brien, DR, Kocher, J-PA, Jones, CD, Mieczkowski, PA, Perou, CM, Skelly, T, Tan, D, Veluvolu, U, Balu, S, Bodenheimer, T, Hoyle, AP, Jefferys, SR, Meng, S, Mose, LE, Shi, Y, Simons, JV, Soloway, MG, Roach, J, Hoadley, KA, Baylin, SB, Shen, H, Hinoue, T, Bootwalla, MS, Van den Berg, DJ, Weisenberger, DJ, Lai, PH, Holbrook, A, Berrios, M, Laird, PW
المصدر: Cell , 169 (7) 1327-1341.e23. (2017)
بيانات النشر: CELL PRESS
سنة النشر: 2017
المجموعة: University College London: UCL Discovery
مصطلحات موضوعية: Cell Biology, RNA-SEQ DATA, LIVER-CANCER, MUTATIONAL LANDSCAPE, THERAPEUTIC TARGETS, EXPRESSION PROFILES, SEQUENCING DATA, GENE, DNA, PREDICTION, DISCOVERY
الوصف: Liver cancer has the second highest worldwide cancer mortality rate and has limited therapeutic options. We analyzed 363 hepatocellular carcinoma (HCC) cases by whole-exome sequencing and DNA copy number analyses, and we analyzed 196 HCC cases by DNA methylation, RNA, miRNA, and proteomic expression also. DNA sequencing and mutation analysis identified significantly mutated genes, including LZTR1, EEF1A1, SF3B1, and SMARCA4. Significant alterations by mutation or downregulation by hypermethylation in genes likely to result in HCC metabolic reprogramming (ALB, APOB, and CPS1) were observed. Integrative molecular HCC subtyping incorporating unsupervised clustering of five data platforms identified three subtypes, one of which was associated with poorer prognosis in three HCC cohorts. Integrated analyses enabled development of a p53 target gene expression signature correlating with poor survival. Potential therapeutic targets for which inhibitors exist include WNT signaling, MDM4, MET, VEGFA, MCL1, IDH1, TERT, and immune checkpoint proteins CTLA-4, PD-1, and PD-L1.
نوع الوثيقة: article in journal/newspaper
وصف الملف: text
اللغة: English
العلاقة: https://discovery.ucl.ac.uk/id/eprint/10038903/1/1-s2.0-S0092867417306396-main.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10038903Test/
الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10038903/1/1-s2.0-S0092867417306396-main.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10038903Test/
حقوق: open
رقم الانضمام: edsbas.4A118FA1
قاعدة البيانات: BASE